- Home
- VFS vs HALO Comparison
VFS vs HALO Comparison
Compare VFS & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VFS
- HALO
- Stock Information
- Founded
- VFS 2017
- HALO 1998
- Country
- VFS Vietnam
- HALO United States
- Employees
- VFS N/A
- HALO N/A
- Industry
- VFS Blank Checks
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VFS Finance
- HALO Health Care
- Exchange
- VFS Nasdaq
- HALO Nasdaq
- Market Cap
- VFS 9.0B
- HALO 8.0B
- IPO Year
- VFS N/A
- HALO N/A
- Fundamental
- Price
- VFS $3.39
- HALO $63.84
- Analyst Decision
- VFS Strong Buy
- HALO Buy
- Analyst Count
- VFS 3
- HALO 9
- Target Price
- VFS $8.00
- HALO $61.63
- AVG Volume (30 Days)
- VFS 583.3K
- HALO 1.6M
- Earning Date
- VFS 04-24-2025
- HALO 05-06-2025
- Dividend Yield
- VFS N/A
- HALO N/A
- EPS Growth
- VFS N/A
- HALO 63.33
- EPS
- VFS N/A
- HALO 3.43
- Revenue
- VFS $1,517,342,313.00
- HALO $1,015,324,000.00
- Revenue This Year
- VFS N/A
- HALO $20.06
- Revenue Next Year
- VFS $57.08
- HALO $23.87
- P/E Ratio
- VFS N/A
- HALO $18.61
- Revenue Growth
- VFS 64.54
- HALO 22.44
- 52 Week Low
- VFS $2.26
- HALO $37.73
- 52 Week High
- VFS $6.42
- HALO $66.00
- Technical
- Relative Strength Index (RSI)
- VFS 48.41
- HALO 62.51
- Support Level
- VFS $3.00
- HALO $63.21
- Resistance Level
- VFS $3.52
- HALO $66.00
- Average True Range (ATR)
- VFS 0.17
- HALO 1.69
- MACD
- VFS 0.03
- HALO -0.03
- Stochastic Oscillator
- VFS 60.56
- HALO 61.57
About VFS VinFast Auto Ltd.
VinFast Auto Ltd manufactures cars, and motor vehicles, renders leasing activities, trades smartphones, and related businesses. The company is engaged in designing and manufacturing premium EVs, e-scooters, and e-buses. The company's initial EV product line is an all-new range of fully electric A- through E-segment SUVs. The Company has three reportable segments, namely Automobiles, E-scooter, Spare parts & Aftermarket services. The Automobiles segment includes the design, development, manufacturing, and sales of cars and electric buses; The E-scooter segment includes the design, development, manufacturing, and sales of e-scooters; the Spare parts & Aftermarket services segment includes the sales of spare parts and rendering of aftermarket services for automobiles and e-scooters.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.